Evofem Biosciences (EVFM) Reports Complete Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy

November 8, 2018 6:51 AM

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced the last patient has completed her last visit in AMPOWER, the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found